NDC 72123-007

Brillia Health Cough Control

Lapine Bradykinin Immune Globulin (12c, 30c, 50c), Lapine Morphine Immune Globulin (12c, 30c, 50c), Lapine Histamine Immune Globulin (12c, 30c, 50c)

Brillia Health Cough Control is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Hadaf Llc. The primary component is Lapine Morphine Immune Globulin; Lapine Bradykinin Immune Globulin; Lapine Histamine Immune Globulin.

Product ID72123-007_ac4f048d-a497-4ece-e053-2995a90a9c93
NDC72123-007
Product TypeHuman Otc Drug
Proprietary NameBrillia Health Cough Control
Generic NameLapine Bradykinin Immune Globulin (12c, 30c, 50c), Lapine Morphine Immune Globulin (12c, 30c, 50c), Lapine Histamine Immune Globulin (12c, 30c, 50c)
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-07-31
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHadaf LLC
Substance NameLAPINE MORPHINE IMMUNE GLOBULIN; LAPINE BRADYKININ IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN
Active Ingredient Strength12 [hp_C]/1; [hp_C]/1; [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72123-007-01

2 BLISTER PACK in 1 BOX (72123-007-01) > 10 TABLET in 1 BLISTER PACK
Marketing Start Date2020-07-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Brillia Health Cough Control" or generic name "Lapine Bradykinin Immune Globulin (12c, 30c, 50c), Lapine Morphine Immune Globulin (12c, 30c, 50c), Lapine Histamine Immune Globulin (12c, 30c, 50c)"

NDCBrand NameGeneric Name
72123-005Brillia Health Cough Controlhomeopathic
72123-007Brillia Health Cough ControlLapine Bradykinin Immune Globulin (12C, 30C, 50C), Lapine Morphine Immune Globulin (12C, 30C, 50C), Lapine Histamine Immune Globulin (12C, 30C, 50C)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.